Wednesday,27 November 2024 08:20:28

Market Report by Email

If you would like to receive the daily Market Report by email please fill out your name and email address in the sign-up form below and you will be added to our mailing list.

Wednesday,27 November 2024 at 08:17

UK & European markets are heading for a mixed open as investors continued to assess the potential impact of President-elect Donald Trump’s plans to hike tariffs.

Asia-Pacific markets were mixed following gains on Wall Street that saw the S&P 500 and the Dow Jones Industrial Average reach new intraday and closing records.

Oil prices steadied in early trade, with markets assessing the potential impact of a ceasefire deal between Israel and Hezbollah, and ahead of Sunday’s OPEC+ meeting.

Gold prices flitted within a narrow range as investors awaited key U.S. inflation data for insights into the potential scale of a Federal Reserve rate cut next month.

In corporate news, low-cost airline EasyJet reported a surge in full-year profit and boosted its dividend on strong summer demand and a narrowing of winter losses.

The company posted a 34% rise in pre-tax profit to £610m. The dividend was lifted to 12.1p a share from 4.5p.

Elsewhere, GSK’s liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process against invasive meningococcal disease (IMD).

Using a single-vial, fully liquid vaccine means reconstitution isn’t needed before use, which should “simplify immunisation and support vaccine uptake”, according to Philip Dormitzer, head of global vaccines R&D at GSK.

Markets

At 08:18

FTSE 100 8,265 +0.08%

FTSE 250 20,585 +0.08%

DAX 19,251 (-0.23%)

At the close

Dow Jones 44,860 +0.28%

S&P 500 6,021 +0.57%

NASDAQ 19,174 +0.63%

Fixed Income

UK 10-YR YIELD 4.320

Exchange Rates

GBP/USD 1.260

GBP/EUR 1.199

Commodities

Gold $2,646 +0.53%

Brent $72.60 +0.28%

Important - No news or research item should be construed as a recommendation to trade. The inclusion of securities within this report does not necessarily imply their suitability for individual portfolios or situations in respect of which further advice should be sought. Information contained in this report has been compiled from sources believed to be reliable but is not warranted to be accurate or complete.